Alaunos Therapeutics Inc. (TCRT)
NASDAQ · Healthcare
Alaunos Therapeutics Inc. EBITDA 2011–2025
Alaunos Therapeutics Inc. annual/quarterly ebitda history and growth rate from 2011 to 2018. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Alaunos Therapeutics Inc. ebitda for the quarter ending March 31, 2018 was -16.1 M, a 13.16% decrease year-over-year.
- Alaunos Therapeutics Inc. annual ebitda for 2016 was -165.0 M, a 62.56% increase from 2012.
- Alaunos Therapeutics Inc. annual ebitda for 2012 was -101.5 M, a 42.71% increase from 2011.
- Alaunos Therapeutics Inc. annual ebitda for 2011 was -71.1 M.
EBITDA
QUARTERLY · $B
Alaunos Therapeutics Inc. EBITDA — FAQ
Alaunos Therapeutics Inc. (TCRT) ebitda over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TCRT's ebitda history?
The chart and table above show Alaunos Therapeutics Inc.'s ebitda by year and by quarter, including the growth rate.